Uncategorized Archives - Page 100 of 112

FridayApr 20, 2018 12:02 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Receives Temporary License to Break Ground on Cannabis Cultivation Facility in California

Permanent, annual state license for this facility to be applied for within the next 120 days Production capacity projected to reach over 100,000 kg of medical cannabis per year Californian facility will provide tenancy for other licensed cannabis cultivators On April 12, 2018, Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) announced that its subsidiaries in the United States have received the necessary temporary licenses from the State of California to proceed with the construction of the company’s cultivation facilities in Cathedral City, California (http://cnw.fm/b4YDt). Licenses are temporary while the state develops permanent regulations for its newly legalized cannabis industry. Sunniva will apply…

ThursdayApr 19, 2018 11:12 am

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) is “One to Watch”

Uniquely positioned in the largest legalized medical and recreational cannabis markets – California and Canada Construction underway for a modern, agri-technology greenhouse facility in California capable of producing over 100,000 kg of premium medical cannabis annually, once phase 1 and 2 are complete Received all required California temporary licenses to cultivate, process cannabis; will apply for annual state licenses within next four months Designs completed for purpose-built current Good Manufacturing Practice (cGMP) compliant greenhouse facilities in British Columbia capable of producing 100,000 kg of premium medical cannabis per year and over 25,000 kg of trim used for extraction Application for…

WednesdayApr 18, 2018 11:29 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Significant Breakthrough with Alternative Nicotine Delivery Technology

Delivery technology already proven effective in cannabinoid delivery, now being studied in nicotine absorption Positive topline results on completion of first ingestible nicotine in vivo (animal) absorption study LXRP’s long-term strategy is to partner with leading firms in the tobacco industry, providing an additional layer of effectiveness in products to their already established consumer base Potential to revolutionize smokeless tobacco and the tobacco industry The drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has announced a significant breakthrough in alternative nicotine delivery technology. This cannabis-focused food bioscience company has a proprietary technology for improved delivery of bioactive…

MondayApr 16, 2018 12:59 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Looking Forward to 2018 Senate Bill Addressing Regulation of Hemp

Sen. Mitch McConnell (R-KY) is a lead sponsor of ‘The Hemp Farming Act of 2018’, which would remove hemp from scheduled list of controlled substances, making it a legal crop Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is joining other leaders in the hemp industry through its anticipation of the impending Senate bill, sponsored by Majority Leader Mitch McConnell, that would remove hemp from the scheduled list of controlled substances in the U.S. and, instead, make it an agricultural commodity (http://cnw.fm/0QaGf). “It’s now time to take the final step and make this a legal crop,” Sen. McConnell said…

FridayApr 13, 2018 11:09 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expands Patented Drug Delivery Portfolio with New Breakthroughs

Novel drug delivery system scientifically proven to increase absorption, bioavailability and efficacy New U.S. patents awarded, strengthening company’s IP portfolio Wide variety of patent families with ranging applications Building off DehydraTECH™, its patented lipophilic drug delivery platform, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has received another new Notice of Allowance from the United States Patent and Trademark Office that protects the company’s processes for making specific compositions of matter for enhanced cannabinoid delivery (http://cnw.fm/yN7AQ). This latest announcement comes on the heels of Lexaria’s March 22, 2018, press release that announced its receipt of a Notice of Allowance for the…

WednesdayApr 11, 2018 1:47 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Provides Update on Bio-Cannabis Product Pipeline

Several proprietary products developed and ready to market in Canada, California and global markets Cannabis product sales expected to generate significant revenue Pivot’s IP portfolio includes global patents to cement its leading position in the cannabis industry On April 4, 2018, Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) published an update on the advancements of its industry-leading cannabis product pipeline (http://cnw.fm/37EFo). A newly developed 1% cannabidiol (CBD) oral micelle solution, created in collaboration with the company’s German technology partner, Solmic GmbH, is ready to market. The development of two topical creams using Pivot’s patented formulation and delivery systems…

WednesdayApr 11, 2018 11:11 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Tech Promises Versatile Commercial Applications

DehydraTECH™ has been shown to improve the taste, smell, bioabsorption and bioavailability of high performance ingestible consumer products Lexaria is working to eliminate negative side effects and enhance the healthy benefits of a variety of bioactive compounds Research being conducted for healthier oral ingestion of vitamins, nicotine and opioids DehydraTECH™ is a unique enabling technology from Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) that increases the absorption rate of edible ingestion, delivering five to 10 times more of active ingredients than traditional edibles. This technology is not a competing technology but rather a complementary layer that provides a versatile range…

TuesdayApr 10, 2018 10:43 am

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) Growing Patent Portfolio Enables Commercialization, Defense of DehydraTECH

LXRP recently received a new U.S. patent allowance for ‘composition of matter’ related to its DehydraTECH™ platform’s delivery of cannabinoids; based on past experience, company expects formal granting of patent within 100 days Company filed new U.S. patent application for use of DehydraTECH to improve the speed of absorption of active pharmaceutical ingredients through the skin; compared to other commercial formulations, LXRP product exhibited up to a 225 percent increase in permeability LXRP gets primary revenue through third party licensing fees related to its proprietary and patented intellectual property; goal is to partner with leading firms globally to deliver best-in-class…

FridayApr 06, 2018 2:00 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Extracts Maximum Benefit from Cannabis Portfolio

Forecasts predict $55.8 billion valuation for medical cannabis market by 2025 Pivot Pharmaceuticals building portfolio of diverse tech for improving bioavailability of cannabinoid therapies Company’s leadership team builds on decades of experience in pharmaceutical arena For nutrition-conscious consumers, scanning food product labels is a requisite part of any trip to the grocery store, but a recent study by the U.S. Department of Agriculture’s Agricultural Research Service (http://cnw.fm/i21Ex) found that the old maxim ‘what you see isn’t always what you get’ holds true when it comes to certain foods like nuts. Even though pistachios, for example, may have 161.9 calories per ounce,…

WednesdayApr 04, 2018 1:38 pm

Xanthic Biopharma Inc. Establishing a New Paradigm in Cannabinoid Delivery

Filed patents to protect company’s process and products Powderized cannabis products deliver precise CBD/THC dosing with superior cannabinoid solubility Signed strategic partnership and licensing agreement with Avitas CBD Water After thousands of years of human use, cannabis is now at the center of a new revolution. The medical efficacy of certain cannabinoids is now settled science, and numerous advanced therapeutic applications are currently in development. Recreational cannabis use has gained broad acceptance in multiple U.S. states and, in a few months, becomes legal across all of Canada. However, whether for medicinal or recreational purposes, there have been long-standing problems with…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 512.354.7000

Category: Uncategorized